TSPAN1 and cholangiocarcinoma: Previous study showed that TSPAN1 promoted EMT and metastasis of cholangiocarcinoma via promoting PI3K/AKT pathway, suggesting that TSPAN1 may be a potential therapeutic target for cholangiocarcinoma [18].